- Home
- WLY vs BHC Comparison
WLY vs BHC Comparison
Compare WLY & BHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WLY
- BHC
- Stock Information
- Founded
- WLY 1807
- BHC N/A
- Country
- WLY United States
- BHC Canada
- Employees
- WLY N/A
- BHC N/A
- Industry
- WLY Books
- BHC Biotechnology: Pharmaceutical Preparations
- Sector
- WLY Consumer Discretionary
- BHC Health Care
- Exchange
- WLY Nasdaq
- BHC Nasdaq
- Market Cap
- WLY 2.2B
- BHC 2.6B
- IPO Year
- WLY N/A
- BHC N/A
- Fundamental
- Price
- WLY $41.75
- BHC $5.27
- Analyst Decision
- WLY
- BHC Hold
- Analyst Count
- WLY 0
- BHC 5
- Target Price
- WLY N/A
- BHC $7.20
- AVG Volume (30 Days)
- WLY 578.2K
- BHC 1.5M
- Earning Date
- WLY 03-06-2025
- BHC 04-30-2025
- Dividend Yield
- WLY 3.18%
- BHC N/A
- EPS Growth
- WLY N/A
- BHC N/A
- EPS
- WLY 0.75
- BHC N/A
- Revenue
- WLY $1,703,491,000.00
- BHC $9,625,000,000.00
- Revenue This Year
- WLY N/A
- BHC $4.76
- Revenue Next Year
- WLY $1.13
- BHC $2.05
- P/E Ratio
- WLY $60.63
- BHC N/A
- Revenue Growth
- WLY N/A
- BHC 9.91
- 52 Week Low
- WLY $34.85
- BHC $3.96
- 52 Week High
- WLY $53.96
- BHC $10.48
- Technical
- Relative Strength Index (RSI)
- WLY 44.47
- BHC 23.66
- Support Level
- WLY $43.96
- BHC $6.91
- Resistance Level
- WLY $45.56
- BHC $7.45
- Average True Range (ATR)
- WLY 0.87
- BHC 0.27
- MACD
- WLY -0.25
- BHC -0.13
- Stochastic Oscillator
- WLY 18.84
- BHC 1.39
About WLY John Wiley & Sons Inc.
John Wiley & Sons Inc is a provider of academic journals, books, pre- and post-hire assessments and training, test preparation materials, and online education program management solutions. The company's reportable segments are; Research, Learning, Held for Sale or Sold. The majority of the company's revenue is generated from the Research segment which provides peer-reviewed scientific, technical, and medical (STM) publishing, content platforms, and related services to academic, corporate, and government customers, academic societies, and individual researchers. Geographically, it derives maximum revenue from the United States and the rest from the United Kingdom, China, Japan, Canada, and other countries.
About BHC Bausch Health Companies Inc.
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.